FDA Orange Book · active-ingredient family
Estradiol cypionate; medroxyprogesterone acetate
Estradiol cypionate; medroxyprogesterone acetate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:LUNELLE · NDA 020874
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| LUNELLERLD | PHARMACIA AND UPJOHN | NDA 020874 | — | Oct 05, 2000 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Estradiol cypionate; medroxyprogesterone acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
